Sharif Zain I, Heist E Kevin
Clinical Cardiac Electrophysiology Department, Massachusetts General Hospital, Boston, MA, USA.
J Innov Card Rhythm Manag. 2021 May 15;12(5):4507-4518. doi: 10.19102/icrm.2021.120505. eCollection 2021 May.
Radiofrequency ablation (RFA) remains a highly effective therapy in the management of paroxysmal atrial fibrillation (PAF) and is an important therapeutic option in the management of persistent atrial fibrillation (PeAF) when clinically indicated. Lesion size is influenced by many parameters, which include those related to energy application (RFA power, temperature, and time), delivery mechanism (electrode size, orientation, and contact force), and the environment (blood flow and local tissue contact, stability, and local impedance). Successful durable RFA is dependent on achieving lesions that are reliably transmural and contiguous, whilst also avoiding injury to the surrounding structures. This review focuses on the variables that can be adjusted in connection with RFA to achieve long-lasting lesions that enable patients to derive the maximum sustained benefit from pulmonary vein isolation and additional lesion sets if utilized.
射频消融(RFA)仍然是阵发性心房颤动(PAF)管理中的一种高效治疗方法,并且在临床指征明确时,是持续性心房颤动(PeAF)管理中的重要治疗选择。病变大小受许多参数影响,这些参数包括与能量应用相关的参数(RFA功率、温度和时间)、输送机制(电极大小、方向和接触力)以及环境因素(血流和局部组织接触、稳定性和局部阻抗)。成功的持久RFA取决于实现可靠的透壁且连续的病变,同时还要避免对周围结构造成损伤。本综述重点关注与RFA相关的可调节变量,以实现持久的病变,使患者能够从肺静脉隔离以及(如适用)额外的病变组中获得最大的持续益处。